EUVIMEDEUVIMED entdecken
Crossref

DAX-1 in sex determination and gonadal development: revisiting the anti-testis hypothesis

Barbara Bardoni iD, Enzo Lalli iD

Endocrine Reviews · 20.06.2026

DOI: 10.1210/endrev/bnag021 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Endocrine Reviews, online erschienen am 20.06.2026. Verfasst von Barbara Bardoni und 1 weiteren Autor:innen. Beteiligte Einrichtung: Institut de Pharmacologie Moléculaire et Cellulaire CNRS UMR7275 - Inserm U1323 -Université Côte d'Azur 660 route des Lucioles - Sophia Antipolis 065…. Die Arbeit nennt 162 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

DAX-1 (NR0B1) is a pivotal regulator of mammalian reproductive and endocrine development. Discovered as a gene whose dosage imbalance can reverse sex in XY individuals, DAX-1 is now recognized as a key component of the network controlling gonadal formation and function. Despite decades of research, the molecular mechanisms of its function in gonad development and function remain only partially understood. We combine genetic, developmental, molecular, and biochemical perspectives to present how DAX-1 regulates gene expression from early sex determination and gonadal differentiation to the maintenance of steroidogenic homeostasis in adrenal and gonadal tissues. Recent advances have reshaped our view of DAX-1 beyond its classical role as a transcriptional repressor. Evidence shows that it functions within dynamic transcriptional networks, interacting with regulators such as SF-1 (NR5A1), SOX9, and other nuclear receptors to fine-tune gene expression in a context-dependent manner. Genomic, structural, and proteomic studies reveal that DAX-1 participates in complexes integrating developmental and hormonal cues, coordinating differentiation and steroidogenesis. Moreover, its emerging roles in RNA-associated gene regulation broaden its functions beyond canonical nuclear receptor signaling. We revisit DAX-1 contribution to sex determination and differentiation from an evolutionary and mechanistic viewpoint, emphasizing its interactions with the SRY–SOX9 axis and its dosage-sensitive influence on gonadal fate. The developmental and clinical consequences of DAX-1 mutations and copy number variations manifest as a spectrum of human phenotypes, from adrenal hypoplasia congenita to differences/disorders of sex development, highlighting its essential role in maintaining endocrine balance.

Schlagwörter

Stichwörter der Autor:innen

gonadogenesisnuclear receptorssteroidogenesistranscriptional regulation

Autor:innen und Institutionen

  • Institut de Pharmacologie Moléculaire et Cellulaire CNRS UMR7275 - Inserm U1323 -Université Côte d'Azur 660 route des Lucioles - Sophia Antipolis 06560 Valbonne France.

ORCID-Profile: Barbara Bardoni, Enzo Lalli

Zitieren

APA

Bardoni, B., & Lalli, E. (2026). DAX-1 in sex determination and gonadal development: revisiting the anti-testis hypothesis. Endocrine Reviews. https://doi.org/10.1210/endrev/bnag021

Vancouver

Bardoni B, Lalli E. DAX-1 in sex determination and gonadal development: revisiting the anti-testis hypothesis. Endocrine Reviews. 2026. doi:10.1210/endrev/bnag021

BibTeX
@article{Bardoni2026,
  author = {Bardoni, Barbara and Lalli, Enzo},
  title = {DAX-1 in sex determination and gonadal development: revisiting the anti-testis hypothesis},
  journal = {Endocrine Reviews},
  year = {2026},
  doi = {10.1210/endrev/bnag021}
}
Kostenlos starten →